linkedin

Take The Right Step to Advance Your Molecule Take The Right Step to Advance Your Molecule

Advanced
Technology
  • Proprietary Cell Line, S-CHOice®
  • Proprietary Bispecific Platform, S-DUAL™
  • Systematic Developability Assessment, DEVELOPICK™
Diverse
Portfolio
  • Breadth of experience with a wide range of molecule types including monoclonal antibody, bispecific antibody, fusion protein, recombinants
Tailored
Execution
  • Dedicated project management team to ensure a smooth transition from discovery to clinical

Bring your sequence, we’ll take you to IND

From development to clinical and commercial, we work with commercialization in mind. Our development experts generate and optimize scalable, robust process for reliable support of our clients’ clinical and long-term commercial supply.

By connecting all aspects of development to clinical and commercial production, we are able to achieve optimal yield, quality, and stability for a reliable clinical supply.

Discovery
  • S-DUAL™ - Bispecific Antibody Platform
  • DEVELOPICK™ - Developability Assessment Platform
Cell Line
Development
  • S-CHOice® and CHOZN® Platforms
  • High productivity with titers up to 7.0g/L
Process
Development
  • Media screening and process optimization
  • Buffer and excipient screening
  • Assay development and characterization studies
Non-GMP DS/
DP Production
  • Scale: 50L or 200L bioreactors
  • Non-GMP DS/DP stability data to support cGMP DS/DP stability
cGMP DS/
DP Production
  • Scale: 200L and 1,000L bioreactors
  • DS/DP stability study
  • In-house, clinical- scale DS/DP manufacturing
IND Filing
Support
  • IND/IMPD CMC documentation support
  • IND filing support with Module 2.3 & 3 of CTD and Type V drug Master File
Clinical

Related Contents

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please sign up to view the post.

Please sign up to view the post.
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION